Maribavir
- Generic Name
- Maribavir
- Brand Names
- Livtencity
- Drug Type
- Small Molecule
- Chemical Formula
- C15H19Cl2N3O4
- CAS Number
- 176161-24-3
- Unique Ingredient Identifier
- PTB4X93HE1
- Background
Maribavir is an inhibitor of the cytomegalovirus (CMV; HHV5) pUL97 kinase which is used to treat CMV infections in patients post-transplantation. Most standard CMV therapies, such as ganciclovir or foscarnet, target CMV DNA polymerase - while generally effective, these medications tend to promote the development of CMV resistance to DNA polymerase-based ther...
- Indication
Maribavir is indicated for the treatment of post-transplant cytomegalovirus (CMV) infection (following hematopoietic stem cell transplant or solid organ transplant) which is refractory to standard treatment with ganciclovir, valganciclovir, cidofovir, or foscarnet.
...
- Associated Conditions
- Post-transplant Cytomegalovirus (CMV) Infection
- Associated Therapies
- -
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.